Royalty Pharma reported revenue of $674.14M and net income of $81.49M for the quarter ended Jun 2026, up 16.5% year over year. This income statement covers 29 quarters of results from Jun 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||||||||||||||||||||||
| Revenue | 585.77M | 575.70M | 562.05M | 535.96M | 573.46M | 565.75M | 683.97M | 538.20M | 536.31M | 596.07M | 567.98M | 537.27M | 564.69M | 593.64M | 568.25M | 578.66M | 609.29M | 621.99M | 630.58M | 674.14M | |||||||||
| Operating items | |||||||||||||||||||||||||||||
| Amortization - Intangibles | 5.80M | 5.80M | 5.67M | ||||||||||||||||||||||||||
| Research & DevelopmentR&D | 90.50M | 103.80M | 100.50M | 0.61M | 25.50M | 50.50M | 0.50M | 0.50M | 50.50M | 0.50M | 0.50M | 0.50M | 0.50M | 0.50M | 50.50M | 300.50M | 50.50M | 50.50M | 39.80M | 97.90M | |||||||||
| Selling, General & AdministrativeSG&A | 48.59M | 46.16M | 51.54M | 51.84M | 50.69M | 73.23M | 85.69M | 47.63M | 57.23M | 59.19M | 57.65M | 54.71M | 56.72M | 67.59M | 110.70M | 179.77M | 118.73M | 164.27M | 159.49M | 161.89M | |||||||||
| Other Operating ExpensesOther Opex | 143.63M | 272.32M | 190.29M | 105.71M | 305.06M | 924.67M | 118.80M | 241.23M | 277.14M | -76.51M | 583.60M | 212.43M | -227.60M | 164.04M | -127.14M | -111.40M | 12.90M | 18.84M | -131.75M | 281.24M | |||||||||
| Operating ExpensesOpex | 282.72M | 422.28M | 342.33M | 158.16M | 381.25M | 1,048.40M | 205.00M | 289.36M | 384.87M | -16.83M | 641.75M | 267.64M | -170.38M | 232.13M | 34.06M | 368.87M | 182.13M | 233.61M | 67.54M | 541.02M | |||||||||
| Operating IncomeOp. Inc | 303.05M | 153.42M | 219.72M | 377.79M | 192.21M | -482.65M | 478.97M | 248.84M | 151.44M | 612.90M | -73.77M | 269.63M | 735.07M | 361.51M | 534.18M | 209.80M | 427.16M | 388.38M | 563.04M | 133.12M | |||||||||
| EBIT | 303.05M | 153.42M | 219.72M | 377.79M | 192.21M | -482.65M | 478.97M | 248.84M | 151.44M | 612.90M | -73.77M | 269.63M | 735.07M | 361.51M | 534.18M | 209.80M | 427.16M | 388.38M | 563.04M | 133.12M | |||||||||
| Non-operating items | |||||||||||||||||||||||||||||
| Non Operating Interest Expenses | 44.33M | 46.97M | 47.06M | 46.97M | 46.98M | 46.95M | 46.95M | 46.95M | 46.03M | 47.26M | 44.23M | 49.01M | 66.51M | 65.76M | 65.26M | 68.67M | 79.56M | 94.17M | 93.72M | 93.62M | |||||||||
| Non Operating Investment IncomeNon-Op. Investment Inc. | 11.76M | ||||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 12.26M | 10.64M | 9.53M | 10.92M | 14.03M | 43.85M | 16.70M | 25.65M | 23.44M | 6.50M | 7.42M | 13.38M | 17.51M | 9.04M | 11.29M | 8.33M | 6.90M | 7.07M | 6.23M | 5.13M | |||||||||
| Other Non Operating IncomeOther Non Op Inc. | -16.97M | -0.10M | -1.76M | 71.81M | 25.79M | -0.98M | 7.09M | 1.09M | -8.68M | -18.31M | -3.69M | 6.00M | 3.00M | -9.00M | -3.06M | -1.54M | 4.00M | -8.17M | -2.20M | -1.50M | |||||||||
| Non Operating IncomeNon Op. Inc. | -81.26M | -99.75M | -91.64M | 113.81M | 28.20M | -127.38M | 30.12M | 102.50M | -29.36M | 104.69M | 69.50M | -75.25M | 71.28M | -27.16M | -99.75M | -117.16M | 17.05M | -32.47M | -94.78M | -51.63M | |||||||||
| Net income details | |||||||||||||||||||||||||||||
| EBT | 221.80M | 53.67M | 128.08M | 491.60M | 220.41M | -610.03M | 509.09M | 351.34M | 122.08M | 717.59M | -4.27M | 194.38M | 806.36M | 334.35M | 434.43M | 92.64M | 444.21M | 355.91M | 468.26M | 81.49M | |||||||||
| Profit After TaxPAT | 221.80M | 53.67M | 128.08M | 491.60M | 220.41M | -610.03M | 509.09M | 351.34M | 122.08M | 717.59M | 4.78M | 194.38M | 806.36M | 334.35M | 434.43M | 92.64M | 444.21M | 355.91M | 468.26M | 81.49M | |||||||||
| Equity Income | 2.75M | -38.02M | 0.40M | 0.74M | -3.25M | -6.86M | 34.61M | -0.77M | -5.22M | 0.27M | -14.15M | 1.70M | 10.41M | 31.65M | 6.44M | 2.69M | 15.95M | 4.00M | 21.76M | 4.08M | |||||||||
| Income from Non-Controlling InterestsInc. Minority | 119.87M | 45.77M | 76.32M | 187.09M | 77.76M | -153.95M | 168.33M | 123.71M | 49.96M | 223.25M | -9.05M | 92.37M | 262.37M | 126.14M | 195.08M | 60.46M | 155.99M | 141.71M | 173.57M | 63.60M | |||||||||
| Income from Continuing OperationsIncome (Continuing) | 221.80M | 53.67M | 128.08M | 491.60M | 220.41M | -610.03M | 509.09M | 351.34M | 122.08M | 717.59M | -4.27M | 194.38M | 806.36M | 334.35M | 434.43M | 92.64M | 444.21M | 355.91M | 468.26M | 81.49M | |||||||||
| Consolidated Net IncomeConsol Net Inc. | 221.80M | 53.67M | 128.08M | 491.60M | 220.41M | -610.03M | 509.09M | 351.34M | 122.08M | 717.59M | -4.27M | 194.38M | 806.36M | 334.35M | 434.43M | 92.64M | 444.21M | 355.91M | 468.26M | 81.49M | |||||||||
| Income towards Parent CompanyParent Net Inc | 221.80M | 53.67M | 128.08M | 491.60M | 220.41M | -610.03M | 509.09M | 351.34M | 122.08M | 717.59M | -4.27M | 194.38M | 806.36M | 334.35M | 434.43M | 92.64M | 444.21M | 355.91M | 468.26M | 81.49M | |||||||||
| Net Income towards Common StockholdersNet Income | 221.80M | 53.67M | 128.08M | 491.60M | 220.41M | -610.03M | 509.09M | 351.34M | 122.08M | 717.59M | -4.27M | 194.38M | 806.36M | 334.35M | 434.43M | 92.64M | 444.21M | 355.91M | 468.26M | 81.49M | |||||||||
| Additional items | |||||||||||||||||||||||||||||
| EPS (Basic) | 0.52 | 0.13 | 0.30 | 1.13 | 0.50 | -1.39 | 1.14 | 0.78 | 0.27 | 1.60 | -0.01 | 0.43 | 1.80 | 0.75 | 1.00 | 0.22 | 1.03 | 0.83 | 1.07 | 0.18 | |||||||||
| EPS (Diluted) | 0.37 | 0.13 | 0.21 | 0.81 | 0.36 | -1.39 | 0.84 | 0.58 | 0.20 | 1.19 | -0.01 | 0.33 | 1.36 | 0.56 | 0.75 | 0.16 | 0.79 | 0.63 | 0.84 | 0.15 | |||||||||
| Shares Outstanding | 428.23M | 414.79M | 433.96M | 436.32M | 439.29M | 437.96M | 445.61M | 450.40M | 448.44M | 447.60M | 448.62M | 451.02M | 447.63M | 448.19M | 435.48M | 423.51M | 431.89M | 429.80M | 436.79M | 445.06M | |||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 607.17M | 414.80M | 607.20M | 607.21M | 607.23M | 437.97M | 607.25M | 605.86M | 601.14M | 602.90M | 597.48M | 596.91M | 592.73M | 594.11M | 578.10M | 562.30M | 559.61M | 564.46M | 556.84M | 556.90M | |||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 607.17M | 607.18M | 607.18M | 607.22M | 607.22M | 607.22M | 607.23M | 601.82M | 598.39M | 597.43M | 597.44M | 594.39M | 589.18M | 589.11M | 566.46M | 583.17M | 579.02M | 577.11M | 576.19M | 575.00M | |||||||||
| EBITDA | 303.05M | 153.42M | 219.72M | 377.79M | 192.21M | -482.65M | 478.97M | 248.84M | 151.44M | 612.90M | -73.77M | 269.63M | 735.07M | 361.51M | 534.18M | 209.80M | 427.16M | 388.38M | 563.04M | 133.12M | |||||||||
| Interest ExpensesInt Expense | 44.33M | 46.97M | 47.06M | 46.97M | 46.98M | 46.95M | 46.95M | 46.95M | 46.03M | 47.26M | 44.23M | 49.01M | 66.51M | 65.76M | 65.26M | 68.67M | 79.56M | 94.17M | 93.72M | 93.62M |